Search research articles
Contact Us
Filters
Showing results (161-170 of 195) with videos related to
Page
of 20
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 24, 2023
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis
Emma Schuster, Nurmaa Dashzeveg, Yuzhi Jia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 12, 2007
Breast cancer risk reduction
Therese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 26, 2010
Breast cancer risk reduction
Therese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Breast Cancer Research and Treatment
|
July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square
|
May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
NPJ Breast Cancer
|
July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 19, 2007
Invasive breast cancer
Robert W Carlson, Benjamin O Anderson, Harold J Burstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2005
Breast cancer
Robert W Carlson, Benjamin O Anderson, Harold J Burstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 26, 2010
Breast cancer: noninvasive and special situations
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 195) with videos related to
Sort By:
Page
of 20
Biorxiv : the Preprint Server for Biology
|
April 24, 2023
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis
Emma Schuster, Nurmaa Dashzeveg, Yuzhi Jia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 12, 2007
Breast cancer risk reduction
Therese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 26, 2010
Breast cancer risk reduction
Therese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Breast Cancer Research and Treatment
|
July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square
|
May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
NPJ Breast Cancer
|
July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 19, 2007
Invasive breast cancer
Robert W Carlson, Benjamin O Anderson, Harold J Burstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2005
Breast cancer
Robert W Carlson, Benjamin O Anderson, Harold J Burstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 26, 2010
Breast cancer: noninvasive and special situations
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Page
of 20